Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Stock Forecast

Stock Price Forecast

The 2 analysts that cover Strata Critical Medical stock have a consensus rating of "Strong Buy" and an average price target of $7.63, which forecasts a 57.32% increase in the stock price over the next year. The lowest target is $7.25 and the highest is $8.00.

Price Target: $7.63 (+57.32%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.25	$7.63	$8.00	$8.00
Change	+49.48%	+57.32%	+64.95%	+64.95%

* Price targets were last updated on Dec 2, 2025.

Analyst Ratings

The average analyst rating for Strata Critical Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26
Strong Buy	1	2	2
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Benjamin Haynor Lake Street	Lake Street	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+64.95%	Dec 2, 2025
Ben Klieve Lake Street	Lake Street	Strong Buy Maintains $6.5 → $7.25	Strong Buy	Maintains	$6.5 → $7.25	+49.48%	Sep 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

218.10M

Decreased by -12.30%

from 248.69M

Revenue Next Year

271.83M

Increased by 24.64%

from 218.10M

EPS This Year

-0.15

from -0.35

EPS Next Year

-0.06

from -0.15

Fiscal Year	FY 2021	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2021	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	50.53M	67.16M	146.12M	225.18M	248.69M	218.10M	271.83M
Revenue Growth	115.61%	32.92%	117.58%	54.11%	10.44%	-12.30%	24.64%
EPS	-0.93	-0.68	-0.38	-0.76	-0.35	-0.15	-0.06
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	249.2M	283.5M
Avg	218.1M	271.8M
Low	186.6M	257.7M

Revenue Growth

Revenue Growth	2025	2026	2027
High	0.2%	30.0%
Avg	-12.3%	24.6%
Low	-25.0%	18.2%

EPS Forecast

EPS	2025	2026	2027
High	-0.16	0.08
Avg	-0.15	-0.06
Low	-0.15	-0.19

EPS Growth

EPS Growth	2025	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.